Intended Use

The Artix™ MT thrombectomy device is indicated for the non-surgical removal of emboli and thrombi from blood vessels, injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel, intended for use in the peripheral vasculature. The Artix™ Thin-Walled Sheath is indicated for the non-surgical removal of emboli and thrombi from blood vessels, injection, infusion, and/or aspiration of fluids, use as a conduit for endovascular devices, and use in facilitating intravascular catheter insertion and guidance in the peripheral vasculature.

Technology

The Artix MT is a single-use, over-the-wire catheter with a self-expanding nitinol element deployed via manual retraction to engage thrombus, deployed through a compatible sheath such as the Artix Thin-Walled Sheath. The sheath facilitates vascular access, provides flow occlusion with a funnel catheter accessory, and allows introduction of endovascular devices. Both devices are tracked over a guidewire under fluoroscopic guidance for minimally invasive thrombus removal in peripheral vessels.

Performance

The devices underwent extensive non-clinical verification and validation testing including packaging, visual inspection, burst, simulated use, hemostasis, tensile, particulate, corrosion, radiopacity, radial force, clot removal, air leak, dye staining, lubricity, vacuum testing, and torque testing. Biocompatibility testing per ISO 10993-1 standards and sterilization validation were completed. No clinical or animal testing was required for equivalence determinations.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    6/28/2024

    3 months
  • 2

    FDA Approval

    10/15/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.